PCA
CLVS

Private Capital Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Private Capital Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-20,500
Closed -$930K – 115
2014
Q3 		$930K Buy
+20,500
New +$856K 0.3% 79
2013
Q4 		– Sell
-36,600
Closed -$2.23M – 114
2013
Q3 		$2.23M Buy
+36,600
New +$2.6M 0.81% 50

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Private Capital Advisors's CLVS Position: Q4 2014 in Review

Private Capital Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2014, closing a stake of 20,500 shares — an estimated $930K sold.

Private Capital Advisors first reported a position in CLVS in Q3 2013 and held it in 2 quarters. The position peaked at $2.23M in Q3 2013. 143 funds tracked by Wall St. Rank hold CLVS as of Q4 2014.

  • Private Capital Advisors reported no remaining Clovis Oncology, Inc. position as of Q4 2014 after selling out during the quarter.
  • Private Capital Advisors sold 20,500 Clovis Oncology, Inc. shares in Q4 2014, an estimated $930K.
  • Private Capital Advisors first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 2 quarters.
  • Private Capital Advisors's Clovis Oncology, Inc. position peaked at $2.23M in Q3 2013.
  • 143 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2014.

Based on Private Capital Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.